Dr. Monther Abu-Remaileh's lab at Stanford University focuses on understanding how cancer cells adapt their metabolism to survive in nutrient-poor environments. By studying the role of lysosomes in nutrient acquisition, particularly in pancreatic cancer, the lab aims to develop new technologies and models to analyze how tumors utilize nutrients. This research may lead to the identification of new therapeutic strategies to target metabolic vulnerabilities in cancer cells.

Dr. Katherine Ferrara's lab focuses on developing advanced imaging technologies to enhance medical procedures, particularly in the fields of interventional radiology and oncology. The lab is working on innovative ultrasound imaging techniques that can provide high-resolution images without radiation exposure, making it safer for patients undergoing procedures like biopsies and treatments for liver and breast cancer. They are also developing specialized imaging systems for children and investigating targeted therapies for pancreatic cancer.

Dr. Michael D. Greicius's lab at Stanford University focuses on Alzheimer's disease, particularly the genetic factors that influence risk for the disease. Using advanced techniques like long-read sequencing, the lab explores how variations in the APOE gene and other relevant genes affect Alzheimer's risk in individuals of different ancestries. The ultimate goal is to identify new therapeutic targets that may lead to better treatments for this devastating disease.

Dr. Thomas J. Montine's lab at Stanford University focuses on understanding the molecular mechanisms behind Alzheimer's disease (AD) and related dementias. The lab employs advanced technologies, including innovative single-cell analyses and machine learning, to identify specific neuronal vulnerabilities and develop new therapeutic targets aimed at preventing or treating these conditions. Their research integrates genetic, anatomical, and pathological insights to provide a comprehensive view of AD and its impact on synaptic function.

Dr. Katrin Andreasson's lab at Stanford University focuses on understanding the roles of immune cells in cognitive decline related to aging and Alzheimer's disease. The research explores how signaling pathways, particularly involving inflammatory signals like prostaglandin E2 (PGE2), affect the function of both peripheral myeloid cells and brain microglia. By investigating these mechanisms, the lab aims to identify potential therapies that could improve cognitive function and mitigate age-related decline.

Dr. Jonathan T.C. Liu's lab at Stanford University focuses on improving the diagnosis and risk assessment for Barrett's esophagus, a condition linked to esophageal cancer. They are developing advanced computational techniques for 3D pathology to provide better insights from biopsies, which can significantly enhance patient treatment decisions. By leveraging machine learning and 3D imaging, the lab aims to make the diagnosis process more accurate and reliable for pathologists.

Dr. Andrew J. Beel's lab at Stanford University focuses on understanding the structure and function of the mitotic chromosome, particularly its central scaffold, which is crucial for proper genetic information dissemination during cell division. The research aims to elucidate the molecular composition and 3D architecture of this scaffold and to develop chemical modulators that could impact cancer cell behavior through scaffold manipulation. This work not only provides fundamental insights into chromosome biology but also has potential implications for cancer therapy.

Dr. Steven G. Boxer's lab at Stanford University focuses on understanding complex biological systems using advanced physical methods. They investigate the mechanics behind antibiotic resistance and how viruses, such as influenza A, fuse with cells. By developing unique techniques in biophysics, they explore how electric fields influence enzyme activity and membrane dynamics, aiming to uncover new insights that can improve our approach to infectious diseases and antibiotic design.

Philip A Beachy's lab at Stanford University focuses on understanding and treating Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), a painful condition that disrupts the lives of millions, particularly women. By exploring the regulation of bladder sensory nerves and the integrity of the bladder lining, the lab aims to identify new therapeutic strategies that could replace opioid treatments, thereby reducing addiction risks. Their research utilizes a combination of advanced genetic techniques and cellular analysis to uncover the complex mechanisms behind this condition.

Dr. Helen M. Blau's lab at Stanford University focuses on understanding how aging affects muscle stem cells (MuSCs), which are crucial for muscle repair and regeneration. With the aging population facing challenges like sarcopenia, the lab investigates the mechanisms behind the decline in MuSC function and aims to enhance muscle regeneration through innovative technologies. The research combines cutting-edge single-cell analysis and in vivo experiments to uncover new therapeutic strategies to improve muscle health in elderly individuals.

The research lab, led by Dr. Onn Brandman at Stanford University, investigates how cells respond to stress and maintain the stability of proteins, essential for healthy cell function. By studying the mechanisms of protein production and quality control, the lab seeks to uncover insights into how these processes go awry in diseases and during aging. Their work aims to advance our understanding of cellular survival strategies and the fundamental biology behind diseases.

Dr. Helen Bronte-Stewart's lab focuses on developing innovative therapies to address cognitive decline in Parkinson's disease, particularly before it progresses to dementia. The lab is investigating the use of deep brain stimulation targeting the Nucleus Basalis of Meynert, which is involved in cognitive and motor functions. By optimizing stimulation patterns and patient selection, the research aims to improve cognitive and cognitive-motor outcomes for individuals with Parkinson's disease.

Professor Anne Brunet's lab at Stanford focuses on understanding the biological processes of aging and how the brain affects the aging of other organs. They use unique models like the African killifish to study aging due to its short lifespan and develop advanced tools like machine learning and spatial transcriptomics to analyze complex data. By investigating how the peripheral nervous system and immune cells influence the aging process, the lab aims to uncover potential therapies to enhance longevity and counter age-related diseases.

Dr. Paul S. Buckmaster's lab focuses on understanding the mechanisms that lead to seizures in patients with temporal lobe epilepsy. By studying certain brain cells known as reelin-positive interneurons in both animal models and human cases, the lab aims to identify their role in seizure development. The ultimate goal is to uncover causes of epilepsy that can improve treatment options for affected individuals.

Dr. Ruijiang Li's lab focuses on developing advanced imaging techniques and blood-based biomarkers to personalize cancer treatments, particularly for lung, oropharyngeal, gastric, and rectal cancers. The research aims to enhance prediction of patient responses to immunotherapy and other treatments, which could ultimately improve outcomes and help tailor therapies to individual patients' needs.

Dr. Daniel M Spielman's lab at Stanford University is focused on innovative cancer therapies and imaging techniques. Their aim is to improve the treatment and diagnosis of resistant cancers like glioblastoma by utilizing novel lipid-based drugs that target tumor energy metabolism. By developing advanced MRI techniques, the lab is working to better understand metabolic changes in tumors and enhance treatment response monitoring.

Dr. Jan E. Carette's lab focuses on understanding how certain enteroviruses, which can cause severe neurological problems in children, infect human cells. They use advanced human cell models to study these viruses' interactions with host cells, aiming to uncover new ways to prevent or treat diseases caused by these viruses. The lab combines cutting-edge genetic techniques with stem cell biology to explore the molecular mechanisms of viral entry and pathogenesis.

Dr. Rajat Rohatgi's lab at Stanford University focuses on understanding how cells communicate with each other during development and disease. His team investigates key signaling pathways, specifically the Hedgehog and WNT pathways, which are crucial for tissue formation and maintenance. By uncovering how these signals are transmitted within cells, the lab aims to develop new strategies to address diseases such as cancer and congenital disorders.

Dr. Meghan Halley's lab at Stanford University explores the ethical dimensions of patient engagement in drug development for rare diseases. This research addresses the critical challenges and tensions that arise when patient and family groups collaborate with academic institutions and pharmaceutical companies to advance treatment options. By involving diverse stakeholders, the lab aims to create practical strategies for navigating ethical issues that impact research outcomes and enhance public trust in drug development processes.

Dr. Jonathan R. Pollack's lab at Stanford University focuses on studying the role of the immune system in benign prostatic hyperplasia (BPH), a condition that can cause urinary problems as men age. The lab investigates how specific T-cells contribute to the development of BPH and the factors that trigger these immune responses. By exploring these mechanisms, the research aims to develop better prevention and treatment strategies for this common condition.